These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28060405)

  • 61. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
    Holzer GW; Falkner FG
    Methods Mol Med; 2003; 76():565-78. PubMed ID: 12526185
    [No Abstract]   [Full Text] [Related]  

  • 62. PCR-based method for the introduction of mutations in genes cloned and expressed in vaccinia virus.
    Lorenzo MM; Blasco R
    Biotechniques; 1998 Feb; 24(2):308-13. PubMed ID: 9494734
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Construction and antigenic evaluation of a recombinant MVA virus-like particle expressing HBV C gene].
    Luan XL; Kong W; Liu SJ; Lei L; Hu Y; Hou J; Shen HH; Wu YC; You SL; Mao PY; Xin SJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):252-4. PubMed ID: 18250055
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells.
    Kerr SM; Smith GL
    Virology; 1991 Feb; 180(2):625-32. PubMed ID: 1989387
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Isolation of cis-acting vaccinia virus DNA fragments promoting the expression of herpes simplex virus thymidine kinase by recombinant viruses.
    Vassef A; Mars M; Dru A; Plucienniczak A; Streeck RE; Beaud G
    J Virol; 1985 Jul; 55(1):163-72. PubMed ID: 2989553
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Construction and Function Verification of a Novel Shuttle Vector Containing a Marker Gene Self-deletion System].
    Li L; Wang Z; Zhou Y; Zhang F; Shen S; Li Z; Zeng Y
    Bing Du Xue Bao; 2015 Sep; 31(5):507-14. PubMed ID: 26738288
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recombinant viruses obtained from co-infection in vitro with a live vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus display different plaque phenotypes and loss of the transgene.
    Hansen H; Okeke MI; Nilssen O; Traavik T
    Vaccine; 2004 Dec; 23(4):499-506. PubMed ID: 15530698
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Non-replicating recombinant vaccinia virus expressing CD80 to enhance T-cell stimulation.
    Zajac P
    Methods Mol Biol; 2009; 514():151-62. PubMed ID: 19048219
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Construction and Isolation of Recombinant Vaccinia Virus Expressing Fluorescent Proteins.
    Marzook NB; Newsome TP
    Methods Mol Biol; 2019; 2023():73-92. PubMed ID: 31240671
    [TBL] [Abstract][Full Text] [Related]  

  • 70. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
    Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
    J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Joint production of prime/boost pairs of Fowlpox Virus and Modified Vaccinia Ankara recombinants carrying the same transgene.
    Soprana E; Panigada M; Knauf M; Radaelli A; Vigevani L; Palini A; Villa C; Malnati M; Cassina G; Kurth R; Norley S; Siccardi AG
    J Virol Methods; 2011 Jun; 174(1-2):22-8. PubMed ID: 21419167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
    Carroll MW; Moss B
    Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transient dominant selection of recombinant vaccinia viruses.
    Falkner FG; Moss B
    J Virol; 1990 Jun; 64(6):3108-11. PubMed ID: 2159565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.
    Konetschny C; Holzer GW; Falkner FG
    J Virol; 2002 Feb; 76(3):1236-43. PubMed ID: 11773399
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Generation and applications of HPV pseudovirions using vaccinia virus.
    Sapp M; Selinka HC
    Methods Mol Med; 2005; 119():463-82. PubMed ID: 16350418
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
    Belyakov IM; Wyatt LS; Ahlers JD; Earl P; Pendleton CD; Kelsall BL; Strober W; Moss B; Berzofsky JA
    J Virol; 1998 Oct; 72(10):8264-72. PubMed ID: 9733870
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine].
    Volz A; Fux R; Langenmayer MC; Sutter G
    Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):464-72. PubMed ID: 26697713
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.
    Stittelaar KJ; Kuiken T; de Swart RL; van Amerongen G; Vos HW; Niesters HG; van Schalkwijk P; van der Kwast T; Wyatt LS; Moss B; Osterhaus AD
    Vaccine; 2001 Jun; 19(27):3700-9. PubMed ID: 11395204
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.
    Schneider J; Langermans JA; Gilbert SC; Blanchard TJ; Twigg S; Naitza S; Hannan CM; Aidoo M; Crisanti A; Robson KJ; Smith GL; Hill AV; Thomas AW
    Vaccine; 2001 Sep; 19(32):4595-602. PubMed ID: 11535306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.